INVAMEX

Manufacturer adverse-event records for INVAMEX come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2009–2026 · mid-book · typical Death-code · injury-light

Injury-mix signature

INVAMEX is lighter on Injury codes

Injury-coded event_type share is 1.2% (injury-light tercile) beside 0.13% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for INVAMEX

The standout signal for INVAMEX is Injury-mix: 1.2% Injury-coded (injury-light) beside 0.13% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for INVAMEX. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Malfunction at 9,968 (98.2% of event_type total). Peak single-year volume reaches 2,892 reports across 17 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

10,152
Total Reports
13
Event-type Death
117
Injury Reports
20
Device Types

Event Types

Malfunction 9,968 (98.2%)
Injury 117 (1.2%)
52 (0.5%)
Death 13 (0.1%)
Other 2 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Other 8,233 (80.9%)
1,822 (17.9%)
Hospitalization 51 (0.5%)
Required Intervention 26 (0.3%)
R 14 (0.1%)
Death 13 (0.1%)
O 11 (0.1%)
Disability 4 (0.0%)
H 3 (0.0%)
Congenital Anomaly 3 (0.0%)
D 1 (0.0%)
S 1 (0.0%)

Yearly Trend

09
2009: 1
11
2011: 133
12
2012: 693
13
2013: 2,453
14
2014: 2,751
15
2015: 2,892
16
2016: 1,120
17
2017: 7
18
2018: 16
19
2019: 8
20
2020: 10
21
2021: 8
22
2022: 12
23
2023: 23
24
2024: 14
25
2025: 9
26
2026: 2